IDEAL International Conference 2017
Research, Regulation, and Reimbursement in Surgery and Technologies
May 4th-5th 2017, New York Academy of Medicine, New York City
Twitter @IDEALCollab #IDEAL2017
Promoting innovation and evaluation in modern surgery and other invasive technologies including implants is one of the main challenges in healthcare. IDEAL is a development of Evidence Based Medicine approach designed to provide practical solutions to the real problems of surgery, devices and other complex therapies where randomised trials are often problematic.
The second IDEAL international conference of over one hundred participants focussed on the hottest topics in surgical/interventional care in various clinical areas and celebrated the continuing work of the IDEAL Collaboration. The conference provided real-world context and a wide variety of perspectives from surgeons, methodologists, professional societies, industry, regulators, ethicists, and payers. Plenary lectures were intermixed with parallel educational sessions and discussion opportunities for surgeons and scientists.
Download the final program IDEAL 2017 Final Agenda
Download the presentations below – remaining sessions to follow
| Plenary Session 1: IDEAL Surgical Innovation/Evaluation: current developments
IDEAL Template and specific opportunities – Peter McCulloch, NDS Oxford McCulloch_The IDEAL template Introduction to IDEAL-D – Art Sedrakyan, Weill Cornell Medical College, NY Sedrakyan_IDEAL_Device_talk_NY_2017 (2) IDEAL and Innovation at the FDA – Murray Sheldon/Danica Marinac-Dabic, FDA Sheldon_DMD-IDEAL 2017 IDEAL is a continuously improving work in progress – Jane Blazeby, University of Bristol Blazeby_IDEAL final Clinical Think-Tanks using IDEAL to reflect on case studies Cardiovascular Session – Bruce Campbell, NICE/MHRA, UK Campbell-Bruce_IDEAL Cardiovascular Group Orthopaedic Session – David Beard, SITU, NDORMS, University of Oxford Beard_Ortho Review Plenary Session 2: IDEAL Stakeholder Engagement in Education Education and current surgical research training – Ajit Sachdeva, American College of Surgeons UK perspective: NICE, the MHRA and IDEAL – Bruce Campbell, MHRA P2. Campbell-Bruce_IDEAL NICE MHRA & IDEAL 5 May 2017 v2 Industry exposure to IDEAL: education and outreach – Jesse Berlin, Johnson & Johnson P2. Berlin_Industry exposure to IDEAL (1) Publishing IDEAL – A Conversation with Journal Editors Perspectives from a general medical journal – Elizabeth Loder, British Medical Journal 1. Loder_IDEAL May 2017 An update on the Research Registry and IDEAL studies – Riaz Agha, Intl Journal of Surgery 2. Agha_IDEAL – Research Registry-IDEAL Update May 2017 (3) Surgical journals and IDEAL – style reporting – Justin Dimick, Annals of Surgery and JAMA Surgery Plenary Session 3: Health Technology Assessment and IDEAL IDEAL and HTA – Sean Tunis, Center for Medical Technology Policy (CMTP) Tunis IDEAL-HTA intro 5-5-17 Advancing methods of Health Technology Assessment for medical devices: the EU MedTechHTA Project – Tammy Clifford – CADTH/MedTechHTA Clifford_IDEAL Presentation – MedtecHTA – May 2017 International Society for Pharmacoeconomics and Outcomes Research – Medical devices – Bruce Gingles – Cook Medical/ISPOR To Post – Gingles IDEAL slides final HTA and IDEAL (a “NICE” perspective) – Bruce Campbell – MHRA/NICE Campbell-Bruce_How to apply IDEAL in HTA 5 May 2017 v2 MDEpiNet and NEST Session The history of MDEpiNet and device life-cycle evaluations – Danica Marinac-Dabic, FDA Creating coordinated registry networks & utilising routine data for device research – Art Sedrakyan, Weill Cornell 2. Sedrakyan_MDEpiNet_Update_IDEAL_2017 More efficient evaluation using registries and Bayesian approaches – Marion Campbell, University of Aberdeen 3. Campbell-Marion_IDEAL2017 v2 UDI database interoperability and registries: vascular device examples – Behnaz Minaei, FDA and Phil Goodney, Dartmouth 4. Minaei_IDEAL-UDI-May5th 2017, 5. Goodney_GUIDID5.5.17 Introduction to National Evaluation System for Devices/Technology (NEST) and IDEAL – Bill Murray, MDIC Murray_NESTcc Overview Ideal Conference 2017.05.05
|
PARTNERS
SUPPORTERS
